OXFORD IMMUNOTEC GLOBAL PLC — Net Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/cbab5d8b-bc7e-45ac-b5b4-dcd5acfe7c87/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-1.8M | 2019-01-01 – 2019-12-31 | evidence 0001437749-20-004480 |
| FY 2018 | $120.8M | 2018-01-01 – 2018-12-31 | evidence 0001437749-19-005832 |
| FY 2017 | $-32.9M | 2017-01-01 – 2017-12-31 | evidence 0001437749-18-003397 |
| FY 2016 | $-22.3M | 2016-01-01 – 2016-12-31 | evidence 0001437749-17-003451 |
| FY 2015 | $-24.5M | 2015-01-01 – 2015-12-31 | evidence 0001437749-16-026453 |
| FY 2014 | $-22.2M | 2014-01-01 – 2014-12-31 | evidence 0001437749-15-004137 |
| FY 2013 | $-8.7M | 2013-01-01 – 2013-12-31 | evidence 0001437749-15-004137 |
| FY 2012 | $-14.9M | 2012-01-01 – 2012-12-31 | evidence 0001437749-15-004137 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
OXFORD IMMUNOTEC GLOBAL PLC — all facts · Revenue · Operating Income